1 / 32

IN THE NAME OF GOD

IN THE NAME OF GOD. EPSTEIN-BARR VIRUS INFECTIONS. INCLUDING. INFECTIOUS MONONUCLEOSIS. Dr.Meidani. DEFINITION.

flint
Download Presentation

IN THE NAME OF GOD

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript


  1. IN THE NAME OF GOD dr.MohsenMeidani

  2. EPSTEIN-BARR VIRUSINFECTIONS INCLUDING INFECTIOUS MONONUCLEOSIS Dr.Meidani dr.Mohsen Meidani

  3. DEFINITION • Epstein-Barr virus (EBV) is the cause of heterophile-positive infectious mononucleosis (IM), which is characterized byfever,sorethroat,lymphadenopathy, andatypicallymphocytosis. dr.Mohsen Meidani

  4. EBV is also associated with several human tumors, including nasopharyngeal carcinoma, Burkitt’s lymphoma, Hodgkin’s disease, and (in patients with immunodeficiencies) B celllymphoma. • The virus, a member of the family Herpesviridae, consists of a linear DNA core surrounded by a nucleocapsid and an envelope that contains glycoproteins. dr.Mohsen Meidani

  5. EPIDEMIOLOGY • EBV infections occur worldwide. • These infections are most common in early childhood, with a second peak during late adolescence. • By adulthood, more than 90% of individuals have been infected and have antibodies to the virus. • IM is usually a disease of young adults. dr.Mohsen Meidani

  6. EBV is spread by contact with oral secretions. • The virus is frequently transmitted from asymptomatic adults to infants and among young adults by transfer of saliva during kissing. • Transmission by less intimate contact is rare. • EBV has been transmitted by blood transfusionand by bone marrow transplantation. • More than 90% of asymptomatic seropositive individuals shed the virus in oropharyngeal secretions. dr.Mohsen Meidani

  7. PATHOGENESIS • EBV is transmitted by salivary secretions. • The virus infects the epithelium of the oropharynx and the salivary glands and is shed from these cells. • The virus then spreads through thebloodstream. dr.Mohsen Meidani

  8. Data suggest that memory B cells, not epithelial cells, are the reservoir for EBV in the body. • Cellular immunityis more important than humoral immunity in controlling EBV infection. • If T cell immunity is compromised, EBV-infected B cells may begin to proliferate. dr.Mohsen Meidani

  9. dr.Mohsen Meidani

  10. CLINICAL MANIFESTATIONS dr.Mohsen Meidani

  11. The incubation period for IM in young adults is 4 to 6 weeks. • A prodrome of fatigue, malaise, and myalgia may last for 1 to 2 weeks before the onset of fever, sore throat, and lymphadenopathy. • Fever is usually low-grade and is most common in the first 2 weeks of the illness; however, it may persist for1 month. dr.Mohsen Meidani

  12. Lymphadenopathy and pharyngitis are most prominent during the first 2 weeks of the illness, while splenomegaly is more prominent during the second and third weeks. • Lymphadenopathy most often affects the posterior cervical nodes but may be generalized. • Enlarged lymph nodes are frequently tender and symmetric but are not fixed in place. dr.Mohsen Meidani

  13. dr.Mohsen Meidani

  14. Pharyngitis, often the most prominent sign, can be accompanied by enlargement of the tonsils with anexudate resembling that of streptococcal pharyngitis. • A morbilliform or papular rash, usually on the arms or trunk, develops in 5% of cases. • Most patients treated with ampicillindevelop a macular rash; this rash is not predictive of future adverse reactions to penicillins. dr.Mohsen Meidani

  15. Laboratory Findings • The white blood cell countis usually elevated and peaks at 10,000 to 20,000/L during the second or third week of illness. • Lymphocytosis is usually demonstrable, with >10% atypical lymphocytes. • atypical lymphocytesare enlarged lymphocytes that have abundant cytoplasm, vacuoles, and indentations of the cell membrane. • CD8 cells predominate among the atypical lymphocytes. dr.Mohsen Meidani

  16. Low-grade neutropenia and thrombocytopenia are common during the first month of illness. • Liver function is abnormalin more than 90% of cases. • Serum levels of aminotransferases and alkaline phosphatase are usually mildly elevated. • the serum concentration of bilirubin is elevated in 40% of cases. dr.Mohsen Meidani

  17. dr.Mohsen Meidani

  18. Complications • Most cases of IM are self-limited. • Deaths are very rare and most often are due to central nervous system (CNS) complications, splenic rupture, upper airway obstruction, or bacterial superinfection. dr.Mohsen Meidani

  19. Autoimmune hemolytic anemiaoccurs in 2% of cases during the first 2 weeks. • Nonspecific antibody responsesmay also include rheumatoid factor,antinuclear antibodies, anti–smooth muscle antibodies, antiplatelet antibodies, and cryoglobulins. • IM has been associated with red-cell aplasia, severe granulocytopenia, thrombocytopenia, pancytopenia, and hemophagocytic syndrome. • Splenic ruptureis more common among males than among females and may be manifest as abdominal pain, referred shoulder pain, or hemodynamic compromise. dr.Mohsen Meidani

  20. Hypertrophy of lymphoid tissue in the tonsils or adenoids can result in upper airway obstruction, as can inflammation and edema of the epiglottis, pharynx, or uvula. • Other rare complications associated with acute EBV infection include hepatitis (which can be fulminant), myocarditis or pericarditis with electrocardiographic changes, pneumonia with pleural effusion, interstitial nephritis, genital ulcerations, and vasculitis. dr.Mohsen Meidani

  21. OTHER DISEASES ASSOCIATEDWITH EBV INFECTION • EBV-associated lymphoproliferative disease. • The X-linked lymphoproliferative syndrome (Duncan’s disease). • Oral hairy leukoplakia. • chronic fatigue syndrome. • Chronic active EBV infection. • Burkitt’s lymphoma. • Hodgkin’s disease. • CNS lymphomas in AIDS patients. dr.Mohsen Meidani

  22. dr.Mohsen Meidani

  23. DIAGNOSIS dr.Mohsen Meidani

  24. dr.Mohsen Meidani

  25. The heterophile testis used for the diagnosis of IM in children and adults. • A titer of 40-fold or greateris diagnostic of acute EBV infection in a patient who has symptoms compatible with IM and atypical lymphocytes. • Tests for heterophile antibodies are positive in 40% of patients with IM during the first week of illness and in 80 to 90% during the third week. • Therefore, repeated testing may be necessary, especially if the initial test is performed early. dr.Mohsen Meidani

  26. Tests usually remain positive for 3 months after the onset of illness, but heterophile antibodies can persist for up to 1 year. • These antibodies usually are not detectablein children <5 years of age, in the elderly, or in patients presenting with symptoms not typical of IM. • False-positive monospotresults are more common in persons with connective tissuedisease, lymphoma, viral hepatitis, and malaria. dr.Mohsen Meidani

  27. Differential Diagnosis • acute infection with cytomegalovirus. • Toxoplasma. • HIV. • human herpesvirus 6. • hepatitis viruses . • drug hypersensitivity reactions. • Rubella. • acute infectious lymphocytosis in children. • lymphoma or leukemia. dr.Mohsen Meidani

  28. TREATMENT • Therapy for IM consists of supportive measures, with rest and analgesia. • Excessive physical activity during the first month should be avoided to reduce the possibility of splenic rupture. • If splenic rupture occurs, splenectomy is required. dr.Mohsen Meidani

  29. Glucocorticoid therapy: Prednisone (40 to 60 mg/d for 2 to 3 days, with subsequent tapering of the dose over 1 to 2 weeks): • airway obstruction • autoimmune hemolytic anemia • severe thrombocytopenia. • Glucocorticoids have also been used in a few selected patients with : • severe malaise and fever • severe CNS • cardiac disease. dr.Mohsen Meidani

  30. Acyclovir, at a dosage of 400 to 800 mg five times daily, has been effective for the treatment of oral hairy leukoplakia(despite common relapses) and some cases of chronic active EBV disease. • The posttransplantation EBV lymphoproliferativesyndrome generally does not respond to antiviral therapy. • When possible, therapy should be directed toward reduction of immunosuppression . dr.Mohsen Meidani

  31. Interferon . • antibody to CD20. • Infusions of donor lymphocytes are often effective for stem cell transplant recipients. • Infusions of EBVspecific cytotoxic T cells. • Infusion of autologous EBV-specific cytotoxic T lymphocytes • The isolation of patients with IM is unnecessary. dr.Mohsen Meidani

  32. THE END dr.Mohsen Meidani

More Related